Medpace Holdings, Inc. (MEDP) Q3 FY25 Earnings Call

Strong bookings and awarded-work growth support 2026 revenue, but elevated pass-throughs and cancellation risk constrain margins.

Q3 FY25 results, source: company transcript and SEC filings
QuarterQ3 FY25
Call date2025-10-24
Length46 minutes
EPS$3.86
EPS consensus$3.50
Revenue$659.9M

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

Other quarters: Q2 FY26 · Q4 FY25 · Q2 FY25

All MEDP earnings · Back to MEDP overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.